1 year return (CAGR)
76.68%
Kelly CRISPR & Gene Editing Technology ETF Exchange (NASDAQ, USD)
XDNA
58.04
+6.56 (+12.74%)
NASDAQ
Loading...
3 year return (CAGR)
61.00%
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
-
Price/Sales
-
Ent value
-
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
-
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 54.52 |
| Daily high | 58.04 |
| Daily low | 54.52 |
| Daily Volume | 2K |
| All-time high | 58.04 |
| 1y analyst estimate | - |
| Beta | - |
| EPS (TTM) | - |
| Dividend per share | 0.00 |
| Ex-div date | 8 Dec 2023 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| XDNA | S&P500 | |
| Current price drop from All-time high | -1.86% | -1.13% |
| Highest price drop | -60.84% | -56.47% |
| Date of highest drop | 27 Oct 2023 | 9 Mar 2009 |
| Avg drop from high | -21.23% | -10.68% |
| Avg time to new high | 18 days | 12 days |
| Max time to new high | 487 days | 1805 days |
News
No items found